OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
March 10, 2011
AstraZeneca announced this week that it will discontinue the production of Pulmicort (budesonide) 100 and 200 µg/dose HFA (hydrofluoroalkane) pressurized metered-dose inhaler (pMDI) due to manufacturing issues related to technical aspects of the device, which prevents the ongoing manufacture of the product.
March 03, 2011
Fujifilm and Merck & Co. have formed a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a contract biopharmaceutical manufacturing and development business of Merck.
March 02, 2011
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and type of spending made in 2010 and planned for 2011.
The power of emerging markets is reflected in the pharma's sales and production positions.
Bristol-Myers Squibb opens a new pediatric HIV/AIDS clinic in Tanzania.
Contract manufacturers and fine-chemical suppliers announce capacity expansions and service enhancements of Informex.